← All trials
NCT02786836
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2016
- Primary completion
- Sep 1, 2018
- Completion date
- Sep 1, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 200
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- The University of Texas, DallasLead sponsor
- University of MichiganStudy chair
- University of MichiganCollaborator
- Exalenz Bioscience LTD.Collaborator
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Collaborator
- Medical University of South CarolinaCollaborator
- The University of Texas, DallasSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.